translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
GLOBAL: Aurobindo Uses Patent Pool for Generic AIDS Drugs
Ben Hirschler
October 11, 2011
Reuters (10.11.11) - Tuesday, October 11, 2011

Aurobindo Pharma has become the first major generic drugmaker to join the Medicines Patent Pool, a move the MPP said would allow the pharmaceutical firm to make a number of HIV/AIDS drugs licensed to the pool by Gilead Sciences. Created by the UNITAID health financing system and funded by a tax on airline tickets, MPP aims to help address the need for low-cost HIV/AIDS drugs by creating a system where patent holders can license technology to generic manufacturers. Aurobindo will take advantage of a provision that will allow it to sell one drug, tenofovir, to a range of countries without paying royalties. These could include such middle-income nations as Argentina, Brazil, Chile, Colombia, Malaysia, the Philippines, Ukraine, and Uruguay.